AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,528.00p
   
  • Change Today:
    164.00p
  • 52 Week High: 12,940.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.71m
  • Volume: 1,220,042
  • Market Cap: £194,273m
  • RiskGrade: 123
  • Beta: 1.33

Latest ShareCast News

AstraZeneca's Koselugo receives EU approval

By Iain Gilbert

Date: Tuesday 28 Oct 2025

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo asset has been approved for usage in the European Union for the rare, progressive, genetic condition, plexiform neurofibromas, in adults with neurofibromatosis type 1.

AstraZeneca ShareCast News

Astrazeneca's Tezspire secures EU approval 22-Oct-2025 ShareCast
AstraZeneca lupus treatment gets EU approval 20-Oct-2025 ShareCast
Deutsche Bank downgrades AstraZeneca to 'sell' 16-Oct-2025 ShareCast
AstraZeneca to cut US drug prices in key White H... 13-Oct-2025 ShareCast
AstraZeneca's Baxdrostat hits Phase III endpoint... 07-Oct-2025 ShareCast

AstraZeneca Regulatory News

Result of General Meeting 03-Nov-2025 16:00 RNS
Total Voting Rights 03-Nov-2025 15:00 RNS
Director Declaration 28-Oct-2025 07:05 RNS
Koselugo (selumetinib) approved in the EU 28-Oct-2025 07:00 RNS
Tezspire Approved in EU for CRSwNP 22-Oct-2025 07:00 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,528.00p
Change Today 164.00p
% Change 1.33 %
52 Week High 12,940.00
52 Week Low 9,667.00
Volume 1,220,042
Shares Issued 1,550.71m
Market Cap £194,273m
Beta 1.33
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 04-Nov-2025

Time Volume / Share Price
16:21 1 @ 12,494.00p
16:11 7 @ 12,514.00p
16:08 0 @ 12,496.00p
16:08 0 @ 12,496.00p
16:08 0 @ 12,496.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page